IDXX - IDEXX Laboratories, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
252.90
+1.02 (+0.40%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close251.88
Open251.77
Bid252.87 x 800
Ask252.96 x 900
Day's Range251.12 - 256.35
52 Week Range176.11 - 294.57
Volume478,138
Avg. Volume446,601
Market Cap22B
Beta (5Y Monthly)0.72
PE Ratio (TTM)52.48
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • PR Newswire

    IDEXX Laboratories Announces Third Quarter Results

    WESTBROOK, Maine , Oct. 31, 2019 /PRNewswire/ -- Reports revenue growth of 11% on a reported basis and 12% on an organic basis, driven by Companion Animal Group ("CAG") Diagnostics recurring ...

  • PR Newswire

    IDEXX Laboratories Announces Leadership Changes

    WESTBROOK, Maine, Oct. 24, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced that Jonathan Ayers is stepping down as Chairman and a member of the IDEXX management team, effective November 1, 2019. This decision follows Mr. Ayers's previously announced medical leave of absence from IDEXX due to a bicycling accident, where he suffered a spinal cord injury.

  • PR Newswire

    IDEXX Laboratories to Release 2019 Third Quarter Financial Results

    WESTBROOK, Maine , Oct. 10, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled ...

  • CNW Group

    IDEXX Breakthrough Kidney Function Test Now Key Component of IRIS Staging Guidelines

    WESTBROOK, Maine , Oct. 2, 2019 /CNW/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in veterinary diagnostics and software, today announced that SDMA-based chronic kidney disease (CKD) staging guidelines have now been generated and approved by the International Renal Interest Society (IRIS). IDEXX is working with IRIS to support clinicians in realizing the clinical utility of the SDMA test and in creating tools that help shape the future of veterinary medicine and patient care.

  • PR Newswire

    IDEXX Laboratories to Host 2019 Investor Day

    WESTBROOK, Maine , Aug. 6, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will host ...

  • PR Newswire

    IDEXX Laboratories Announces Second Quarter Results

    WESTBROOK, Maine , Aug. 1, 2019 /PRNewswire/ -- Reports revenue growth of 7% on a reported basis and 9% on an organic basis, driven by Companion Animal Group ("CAG") Diagnostics recurring revenue ...

  • PR Newswire

    IDEXX Laboratories Elects Sam Samad to Board of Directors

    WESTBROOK, Maine , July 18, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced ...

  • PR Newswire

    IDEXX Laboratories to Release 2019 Second Quarter Financial Results

    WESTBROOK, Maine , July 15, 2019 /PRNewswire/ --  IDEXX Laboratories, Inc.  (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled ...

  • PR Newswire

    IDEXX Laboratories Chairman, President and Chief Executive Officer, Jonathan Ayers, Taking Medical Leave of Absence

    WESTBROOK, Maine, July 1, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced that Chairman, President and Chief Executive Officer, Jonathan Ayers, is on a medical leave of absence following a serious bicycling accident that occurred on June 27, 2019. Effective June 28, 2019, the IDEXX Board of Directors has appointed Jay Mazelsky as Interim President and Chief Executive Officer.

  • PR Newswire

    IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

    WESTBROOK, Maine , May 20, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate ...

  • PR Newswire

    IDEXX Laboratories Announces First Quarter Results

    WESTBROOK, Maine , May 1, 2019 /PRNewswire/ --  Reports revenue growth of 7% on a reported basis and 10% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 9% reported and 12% organic ...

  • PR Newswire

    IDEXX CEO Establishes Wild Cat Conservation Foundation

    WESTBROOK, Maine, April 23, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in veterinary diagnostics and software, today announced that its Chairman and Chief Executive Officer, Jonathan Ayers, and his wife, Helaine, have established a foundation that will support conservation of the estimated 40 species of felids in the wild. The Ayers Wild Cat Conservation Trust is endowed by a gift of IDEXX stock from the Ayers family. The foundation will focus on supporting the funding of global wild cat species conservation initiatives and organizations.

  • PR Newswire

    IDEXX Laboratories to Release 2019 First Quarter Financial Results

    WESTBROOK, Maine, April 2, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2019 first quarter financial results for Wednesday, May 1, 2019 before the market opens. Individuals can access a live webcast of the conference call through a link on the IDEXX website, www.idexx.com/investors. To listen to the live conference call, please dial 1-800-230-1092 or 1-612-288-0337 and reference confirmation code 465882.

  • PR Newswire

    IDEXX Names Sharon Underberg General Counsel

    WESTBROOK, Maine , March 4, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced ...

  • PR Newswire

    IDEXX Laboratories Announces Fourth Quarter and Full Year 2018 Results

    WESTBROOK, Maine , Feb. 1, 2019 /PRNewswire/ -- Achieves revenue growth in Q4 of 9% on a reported basis and 10% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 12% reported and ...

  • GlobeNewswire

    Consolidated Research: 2019 Summary Expectations for First Data, IDEXX Laboratories, CMS Energy, Worthington Industries, Triumph Group, and Cara Therapeutics — Fundamental Analysis, Key Performance Indications

    NEW YORK, Jan. 24, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • PR Newswire

    IDEXX Expands SediVue Dx® Analyzer Medical Utility and Imaging Capabilities with Latest Software Update

    World's largest veterinary image library powers Neural Network 4.0 advancements WESTBROOK, Maine , Jan. 21, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics ...

  • PR Newswire

    IDEXX Introduces Exclusive Point-of-Care Progesterone Test to Its Catalyst Platform

    WESTBROOK, Maine, Jan. 21, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in veterinary diagnostics and software, today announced that it is introducing a new canine progesterone test for Catalyst Dx® and Catalyst One® chemistry analyzers. This much-anticipated in-house diagnostic will help veterinarians determine when a dog is ready to breed by providing a reliable, quantitative, point-of-care measure of progesterone levels to ascertain ovulation status. IDEXX will begin shipping the new test by the end of March, with initial availability in the United States, Canada, the United Kingdom, France, Germany, and Austria, and will continue shipping to other countries over the course of 2019.

  • PR Newswire

    IDEXX Laboratories to Release 2018 Fourth Quarter and Full-Year Financial Results

    WESTBROOK, Maine, Jan. 9, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2018 fourth quarter and full-year financial results for Friday, February 1, 2019 before the market opens. Individuals can access a live webcast of the conference call through a link on the IDEXX website, www.idexx.com/investors. To listen to the live conference call, please dial 1-800-230-1074 or 1-612-234-9960 and reference confirmation code 462085.